IPO registrations (S-1, F-1) · Registrants

Benitec Biopharma Inc.

SEC CIK

1808898 · filings on EDGAR ↗

Registration

Form S-1, first filed 2020-08-14, last 2024-05-16; 5 initial registrations, 8 amendments

Outcome

Final prospectus filed 2020-10-06; declared effective 2020-10-02

Industry (SIC)

Pharmaceutical Preparations 2834

Incorporated in

DE

Business address

3940 TRUST WAY, Hayward, CA 94545

Ticker

BNTC (Nasdaq)

EDGAR entity type

operating

Insiders and CEO pay

Benitec Biopharma Inc. on the corporate pages

Offering terms

Final price

$60.42 per ADS (424B4 filed 2020-10-06)

Shares sold

2,666,644

Gross proceeds

$161,118,630 before underwriting discounts and any over-allotment option

Listing

Nasdaq under the symbol BNTC

Lead underwriters

H.C. Wainwright

Syndicate

Delivery of the

Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.

On this site

• Form D issuer: Benitec Biopharma Inc. EXACT (CIK (EXACT))
• SEC filer: Benitec Biopharma Inc. EXACT (CIK (EXACT))

Filings 27

Prospectus pages read 2

Officers, directors and large holders Forms 3, 4 and 5

Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.

Private offerings before or after (Form D)

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.

Also on this site Fuzzy

Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.